News | ASTRO | December 06, 2019

ASTRO Congratulates Stephen Hahn, M.D., for Securing Senate Committee Approval to lead FDA

Hahn has served on the ASTRO Board of Directors and has broad knowledge as a clinician, researcher, educator and administrative leader

Stephen Hahn, M.D., FASTRO

Stephen Hahn, M.D., FASTRO

December 6, 2019 — The American Society for Radiation Oncology (ASTRO) expressed its support after the U.S. Senate Committee on Health, Education, Labor and Pensions voted today to approve the nomination of radiation oncologist Stephen Hahn, M,D,, FASTRO, as the next Commissioner of the Food and Drug Administration (FDA). Next, Senate Majority Leader Mitch McConnell (R-Ky.) will need to schedule a full Senate vote to confirm Hahn.

"On behalf of our more than 10,000 members, ASTRO commends Dr. Hahn for his thoughtful answers outlining his commitment to consumer safety during the committee hearing. We are pleased that Dr. Hahn received the votes needed to secure committee approval and will move on to a final confirmation vote. We join the growing number of research, provider and patient groups who also support Dr. Hahn, and we urge the Senate to swiftly confirm his nomination as head of the FDA," said Theodore L. DeWeese, M.D., FASTRO, Chair of the ASTRO Board of Directors.

Hahn, the chief medical executive at the University of Texas MD Anderson Cancer Center in Houston, was nominated Nov. 1 by President Trump to be the nation’s 24th FDA Commissioner. On behalf of ASTRO, DeWeese and other radiation oncology leaders expressed their support of Dr. Hahn's nomination when it was announced by the White House. The Cancer Leadership Council, a coalition of approximately 30 professional societies, cancer patient organizations and research organizations including ASTRO, also voiced its support of Hahn earlier this week.

Related content:

ASTRO supports nomination of Stephen Hahn, M.D., FASTRO, to lead U.S. FDA

Related Content

The interior of the German air force Airbus A-310 Medivac in Cologne, Germany, before its departure to Bergamo, Italy, March 28 to being ferrying COVID-19 patients to Germany for treatment to aid the Italians, whose healthcare system has been overwhelmed by the rapid spread of the coronavirus pandemic. Bundeswehr Photo by Kevin Schrief.

The interior of the German air force Airbus A-310 Medivac in Cologne, Germany, before its departure to Bergamo, Italy, March 28 to being ferrying COVID-19 patients to Germany for treatment to aid the Italians, whose healthcare system has been overwhelmed by the rapid spread of the coronavirus pandemic. Bundeswehr Photo by Kevin Schrief. Find more images from the COVID-19 pandemic.

 

Feature | Coronavirus (COVID-19) | April 08, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Professor David Sebag-Montefiore (Image courtesy of the University of Leeds)

Professor David Sebag-Montefiore (Image courtesy of the University of Leeds)

News | Radiation Therapy | April 07, 2020
April 7, 2020 — An intern...
Eclipse v16 has received CE mark and is 510(k) pending
News | Proton Therapy | April 06, 2020
April 6, 2020 — Driven by its Intelligent Cancer Care approach in developing new solutions that use advanced technolo
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
Recommended best practices for nuclear imaging departments under the COVIF-19 pandemic have been issues by the ASNC and SNMMI. #COVID19 #ASNC #SNMMI #Coronavirus #SARScov2
News | Coronavirus (COVID-19) | April 03, 2020
April 3, 2020 — A new guidance document on best practices to maintain safety and minimize contamination in nuclear im
Jeannie Danker, M.D. #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Jeannie Danker, M.D. Photo courtesy of The Ohio State University Wexner Medical Center

News | Coronavirus (COVID-19) | April 03, 2020 | By Melinda Taschetta-Millane
April 3, 2020 — The radiology world has lost a dedicated leader due to...
Improvised PPE face mask worn by a radiology technologist during rounds atSen. Gerardo M. Roxas Memorial District Hospital in Iloilo City, Philippines. #COVID19 #Coronavirus #SARScov2

Improvised PPE face mask worn by a radiology technologist during rounds at Sen. Gerardo M. Roxas Memorial District Hospital in Iloilo City, Philippines.

Feature | Coronavirus (COVID-19) | April 02, 2020 | Dave Fornell, Editor
There has been an extraordinary demand for personal protective equipment (PPE) with the rapid spread of the novel ...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Coronavirus (COVID-19) | March 31, 2020
March 31, 2020 — In a...